Vanda Pharmaceuticals Stock Price

0.82 (5.03%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.82 5.03% 17.13 20:00:00
Open Price Low Price High Price Close Price Prev Close
16.18 16.17 17.28 16.91 16.31
Bid Price Ask Price Spread News
16.25 17.93 1.68 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,682 608,836 $ 16.88 $ 10,279,979 - 9.00 - 21.8627
Last Trade Time Type Quantity Stock Price Currency
19:58:56 13 $ 17.18 USD


Draw Mode:

Vanda Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 953.08M 55.64M 44.56M $ 248.17M $ 31.15M 0.42 28.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 70.00k 4.80%

more financials information »

Vanda Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VNDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week19.7519.9015.8517.14748,859-2.62-13.27%
1 Month20.7520.7515.8518.48436,148-3.62-17.45%
3 Months17.6921.862715.8519.14477,511-0.56-3.17%
6 Months14.8021.862714.0918.10513,3842.3315.74%
1 Year10.2421.86279.0014.85512,7976.8967.29%
3 Years22.1033.447.1216.36641,735-4.97-22.49%
5 Years12.0933.447.1216.15615,1025.0441.69%

Vanda Pharmaceuticals Description

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.
Your Recent History
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210803 04:21:26